Jeroen Krijgsveld

Title: Jeroen Krijgsveld: Innovator in Antimicrobial Peptides

Introduction

Jeroen Krijgsveld is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of antimicrobial peptides, particularly through his innovative patent work. His research focuses on developing solutions for bacterial and fungal infections, which are critical in both human and veterinary medicine.

Latest Patents

Krijgsveld holds a patent for isolated and recombinant antimicrobial peptides thrombocidin-1 (TC-1) and thrombocidin-2 (TC-2), or variants thereof. This invention relates to peptides that exhibit antimicrobial activity against both gram-positive and gram-negative bacteria, as well as fungi. The patent outlines the use of these peptides in the preparation of medicaments for treating infections such as endocarditis in humans and animals. Additionally, it discusses their application in release systems aimed at preventing bacterial or fungal infections.

Career Highlights

Throughout his career, Jeroen Krijgsveld has worked with prestigious institutions, including the Academic Medical Center at the University of Amsterdam and the University of Twente. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Krijgsveld has collaborated with notable colleagues such as Sebastianus Antonius Johannes Zaat and Jacob Dankert. These partnerships have contributed to the development and refinement of his innovative ideas and patents.

Conclusion

Jeroen Krijgsveld's work in antimicrobial peptides represents a significant advancement in the fight against infections. His contributions through patents and collaborations highlight the importance of innovation in medical research.